PCCS Group Bhd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.196x

PCCS Group Bhd cash flow conversion efficiency. Based on the latest financial reports, PCCS Group Bhd (6068) has a cash flow conversion efficiency ratio of 0.196x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM34.61 Million ≈ $8.69 Million USD) by net assets (RM176.33 Million ≈ $44.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is PCCS Group Bhd worth for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of PCCS Group Bhd (2013–2025)

Cash flow conversion efficiency of PCCS Group Bhd from 2013 to 2025. This chart illustrates how PCCS Group Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View PCCS Group Bhd stock price for real-time trading data and today's change.

PCCS Group Bhd Cash Flow Conversion Ratio Explained

PCCS Group Bhd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

PCCS Group Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PCCS Group Bhd ranked by their cash flow conversion efficiency. Review PCCS Group Bhd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Powerhouse Ventures Ltd
AU:PVL
-0.030x
Loyal Lithium Ltd.
AU:LLI
0.010x
Earlyworks Co., Ltd. American Depositary Shares
NASDAQ:ELWS
-1.245x
CHEMOMAB THERAP. ADR/20
F:2QV0
N/A
PT Cahayasakti Investindo Sukses Tbk
JK:CSIS
0.018x
NEP Realty and Industry Public Company Limited
BK:NEP
-0.011x
Rubberex Corporation M Bhd
KLSE:7803
-0.008x
Madhav Copper Limited
NSE:MCL
0.168x

Annual Cash Flow Conversion Efficiency for PCCS Group Bhd (2013–2025)

The table below shows the annual cash flow conversion efficiency of PCCS Group Bhd from 2013 to 2025. Also see total assets of PCCS Group Bhd for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 RM171.46 Million
≈ $43.05 Million
RM17.65 Million
≈ $4.43 Million
0.103x +140.71%
2024-03-31 RM171.59 Million
≈ $43.08 Million
RM-43.39 Million
≈ $-10.89 Million
-0.253x -486.34%
2023-03-31 RM167.41 Million
≈ $42.03 Million
RM10.96 Million
≈ $2.75 Million
0.065x +177.18%
2022-03-31 RM163.97 Million
≈ $41.17 Million
RM-13.91 Million
≈ $-3.49 Million
-0.085x -337.47%
2021-03-31 RM160.17 Million
≈ $40.21 Million
RM-3.10 Million
≈ $-779.56K
-0.019x -110.33%
2020-03-31 RM153.51 Million
≈ $38.54 Million
RM28.82 Million
≈ $7.24 Million
0.188x -13.44%
2019-03-31 RM140.34 Million
≈ $35.23 Million
RM30.43 Million
≈ $7.64 Million
0.217x +23.05%
2018-03-31 RM125.21 Million
≈ $31.44 Million
RM22.07 Million
≈ $5.54 Million
0.176x +676.67%
2017-03-31 RM86.51 Million
≈ $21.72 Million
RM-2.64 Million
≈ $-663.82K
-0.031x -19.19%
2016-03-31 RM96.91 Million
≈ $24.33 Million
RM-2.48 Million
≈ $-623.90K
-0.026x -235.90%
2015-03-31 RM106.00 Million
≈ $26.61 Million
RM2.00 Million
≈ $502.13K
0.019x -89.13%
2014-03-31 RM121.00 Million
≈ $30.38 Million
RM21.00 Million
≈ $5.27 Million
0.174x +3.22%
2013-03-31 RM113.00 Million
≈ $28.37 Million
RM19.00 Million
≈ $4.77 Million
0.168x --

About PCCS Group Bhd

KLSE:6068 Malaysia Apparel Manufacturing
Market Cap
$15.23 Million
RM60.66 Million MYR
Market Cap Rank
#25883 Global
#741 in Malaysia
Share Price
RM0.28
Change (1 day)
+1.85%
52-Week Range
RM0.26 - RM0.32
All Time High
RM0.60
About

PCCS Group Berhad, an investment holding company, primarily manufactures, markets, and sells apparel in Malaysia, Cambodia, Hong Kong, Singapore, and the People's Republic of China. It operates in four segments: Apparel, Label and Packaging, Credit Financing, and Others. The company also engages in the research and development, manufacturing, import, and export of medical and healthcare products;… Read more